Today: 28 March 2026
Subscribe
Browse Category

NSE:CORR 15 December 2025

Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views

Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views

Corona Remedies shares debuted at ₹1,470 on NSE, a 38% premium to the IPO price of ₹1,062. The stock surged intraday to nearly ₹1,499 and hovered around the mid-₹1,460s by early afternoon, valuing the company near ₹9,000 crore. Trading volumes reached millions of shares. The listing beat grey market forecasts, which had predicted a 28–32% premium.
15 December 2025
··

Stock Market Today

  • Unilever Shares Fall 17% in One Month Amid Valuation Debate
    March 28, 2026, 3:44 PM EDT. Unilever (LSE:ULVR) has seen a sharp 17% decline in its share price over the past month, triggering investor concern. The stock trades at around £44.80, which is 16.4% undervalued compared to a narrative fair value of £53.58 based on earnings and margin forecasts. Recent strategic moves focus on premium Personal Care and Beauty products, aiming to boost margins and profitability through divestitures and acquisitions. However, risks from private label competition and weak emerging markets remain. Despite a higher-than-peer price-to-earnings ratio at 19.8x, the market may be factoring in growth uncertainties, even as Unilever offers resilient longer-term shareholder returns of 10.73% over three years.
Go toTop